← Back to Markets

ASBP

Aspire Biopharma Holdings Inc · NASDAQ NMS - GLOBAL MARKET · Pharmaceuticals

$1.05$-0.08 (-7.08%)

Prices delayed up to 5 minutes

AC Intelligence

AC Intelligence

AC Intelligence for ASBP is being prepared.

Key Stats

Key Stats

Open

$1.11

Day High

$1.15

Day Low

$1.05

Prev Close

$1.13

Volume

0

Avg Volume

961.1K

Day Change

$-0.08

Change %

-7.08%

Fundamentals

Fundamentals

EPS (TTM)

$-4.67

Market Cap

$6M

52-Wk Range

$0.55 — $35.01

Earnings History

Insider Activity

Who Owns This Stock

Who Owns ASBP

Other53.7%25 holders
Dealer / Bank36.3%2 holders
Passive / Index9.8%2 holders

Based on Q4 2025 13F filings + AC behavioral model

30 institutional holders

Top Holders

1.UBS Group AG
$325.0B
2.Crewe Advisors LLC
0.0%$107.3B
3.JANE STREET GROUP, LLC
$75.1B
4.Optivise Advisory Services LLC
$47.1B
5.Vanguard Group
+175.2%$41.5B
6.XTX Topco Ltd
$35.0B
7.Procyon Advisors, LLC
-50.8%$30.7B
8.Geode Capital Management
$30.2B
9.Antara Capital LP
0.0%$26.8B
10.Resolute Advisors LLC
+88.2%$20.6B
11.Three Seasons Wealth, LLC
$16.5B
12.JANE STREET GROUP, LLC
$15.6B
13.Vanguard Group
0.0%$15.1B
14.VR Advisory Services Ltd
$12.8B
15.VR Advisory Services Ltd
$12.8B
16.Verition Fund Management LLC
$12.8B
17.EP Wealth Advisors, LLC
$8.3B
18.P SCHOENFELD ASSET MANAGEMENT LP
$7.7B
19.UBS Group AG
+589.6%$7.0B
20.Scientech Research LLC
$6.8B

Institutional Pressure

Market Regime:Strong Risk-Off (-0.62)
SELLINGBUYING
Neutral
Other(53.7%)
Dealer / Bank(36.3%)
Facilitating
Passive / Index(9.8%)
Holds
Quality / Compounder(0.1%)
Holds through

10% passive + quality floor won't sell.

Updated daily · Based on Q4 2025 filings + AC behavioral model

Sentiment Signals

Sentiment Signals

Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Inst. Flows24 increased/new, 3 decreased/exited (13F)AC 13F Analysis

Sources: SEC Form 4, AC 13F Analysis

On AcidCapitalist

On AcidCapitalist

No recent mentions of ASBP on AcidCapitalist.

Data provided by Finnhub. Prices delayed up to 5 minutes.